Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / Training / Seminars and Symposia / Metabolomics in exploratory toxicology: Consequences of treatment with the candidate chemopreventive agent pentamethylchromanol (PMCol)

Metabolomics in exploratory toxicology: Consequences of treatment with the candidate chemopreventive agent pentamethylchromanol (PMCol)

Jonathan McDunn, Ph.D., Associate Director, Diagnostics Research and Development at Metabolomic Inc. & Adjunct Associate Professor, UNC Department of Biomedical Engineering
When Feb 20, 2013
from 02:00 PM to 03:00 PM
Where G605 Koury (1st floor new Dental School Building)
Add event to calendar iCal

Sponsored by the Center for Environmental Health and Susceptibility (CEHS)